[go: up one dir, main page]

CL2017000069A1 - Derivado de hidantoina. - Google Patents

Derivado de hidantoina.

Info

Publication number
CL2017000069A1
CL2017000069A1 CL2017000069A CL2017000069A CL2017000069A1 CL 2017000069 A1 CL2017000069 A1 CL 2017000069A1 CL 2017000069 A CL2017000069 A CL 2017000069A CL 2017000069 A CL2017000069 A CL 2017000069A CL 2017000069 A1 CL2017000069 A1 CL 2017000069A1
Authority
CL
Chile
Prior art keywords
hydantoin derivative
written
page
formula
acceptable salts
Prior art date
Application number
CL2017000069A
Other languages
English (en)
Inventor
Tatsuya Tamura
Yoshikazu Nishimura
Toru Esaki
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CL2017000069A1 publication Critical patent/CL2017000069A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)

Abstract

<p>LA PRESENTE INVENCIÓN PROPORCIONA COMPUESTOS REPRESENTADOS POR LA FÓRMULA (1) QUE SE MUESTRA A CONTINUACIÓN Y SUS SALES FARMACOLÓGICAMENTE ACEPTABLES:</p> <p>* incluir figura de estructura de hoja resumen (pag 3), escrito 11-01-2017</p> <p>EN DONDE RL, R2, R3, Y R4 SON COMO SE DEFINEN EN LAS REIVINDICACIONES.</p>
CL2017000069A 2012-12-10 2017-01-11 Derivado de hidantoina. CL2017000069A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012269178 2012-12-10

Publications (1)

Publication Number Publication Date
CL2017000069A1 true CL2017000069A1 (es) 2017-08-25

Family

ID=50934349

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2015001391A CL2015001391A1 (es) 2012-12-10 2015-05-22 Compuestos derivados de hidantoina, análogo de pth; composicion farmaceutica; metodo para la prevencion o el tratamieno de osteoporosis,fracturas, hipocondroplasia; y su uso para la produccion de un agente movilizador de celulas madre o un agente para prevenir o tratar osteoporosis, entre otras
CL2017000069A CL2017000069A1 (es) 2012-12-10 2017-01-11 Derivado de hidantoina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2015001391A CL2015001391A1 (es) 2012-12-10 2015-05-22 Compuestos derivados de hidantoina, análogo de pth; composicion farmaceutica; metodo para la prevencion o el tratamieno de osteoporosis,fracturas, hipocondroplasia; y su uso para la produccion de un agente movilizador de celulas madre o un agente para prevenir o tratar osteoporosis, entre otras

Country Status (34)

Country Link
US (5) US9428505B2 (es)
EP (1) EP2930176B1 (es)
JP (1) JP5951799B2 (es)
KR (1) KR102168738B1 (es)
CN (1) CN104854106B (es)
AU (1) AU2013358167B2 (es)
BR (1) BR112015012411B1 (es)
CA (1) CA2892621C (es)
CL (2) CL2015001391A1 (es)
CR (1) CR20150272A (es)
DK (1) DK2930176T3 (es)
ES (1) ES2663797T3 (es)
HR (1) HRP20180647T1 (es)
HU (1) HUE037530T2 (es)
IL (1) IL238277B (es)
LT (1) LT2930176T (es)
MA (1) MA38250B1 (es)
MX (1) MX2015007309A (es)
MY (1) MY178583A (es)
NO (1) NO2930176T3 (es)
NZ (1) NZ707946A (es)
PE (1) PE20151295A1 (es)
PH (1) PH12015501146B1 (es)
PL (1) PL2930176T3 (es)
PT (1) PT2930176T (es)
RS (1) RS57190B1 (es)
RU (1) RU2678984C2 (es)
SA (1) SA515360528B1 (es)
SG (1) SG11201504204XA (es)
SI (1) SI2930176T1 (es)
TW (1) TWI615394B (es)
UA (1) UA115072C2 (es)
WO (1) WO2014092061A1 (es)
ZA (1) ZA201503597B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2433940E (pt) 2009-04-28 2014-12-12 Chugai Pharmaceutical Co Ltd Derivado de espiroimidazolona
CN104854106B (zh) * 2012-12-10 2017-07-04 中外制药株式会社 乙内酰脲衍生物
EP3153166B1 (en) * 2014-06-09 2022-08-03 Chugai Seiyaku Kabushiki Kaisha Hydantoin derivative-containing pharmaceutical composition
TW202019416A (zh) * 2018-07-30 2020-06-01 日商中外製藥股份有限公司 乙內醯脲衍生物的固體分散體
CN110464002A (zh) * 2019-09-12 2019-11-19 西南石油大学 一种天然冰粉的制备方法及其应用
WO2024143501A1 (ja) 2022-12-28 2024-07-04 中外製薬株式会社 分散対象物質を含む固体分散体、それを含む医薬組成物及びそれらの製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1135470A (ja) * 1997-07-23 1999-02-09 Teijin Ltd ビタミンｄ３誘導体を含有する副甲状腺ホルモン産生促進剤
TR200101644T2 (tr) 1998-12-11 2001-11-21 F.Hoffmann-La Roche Ag TNF-ALFA önleyicileri olarak siklik hidrazin türevleri.
US7004593B2 (en) * 2002-06-06 2006-02-28 Donnelly Corporation Interior rearview mirror system with compass
AU2001284412A1 (en) * 2000-08-30 2002-03-13 Teijin Limited Parathyroid hormone production inhibitors containing vitamin D3 derivatives
CA2425283A1 (en) * 2000-10-26 2002-05-02 Pfizer Products Inc. Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
AR038658A1 (es) 2001-06-15 2005-01-26 Novartis Ag Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
WO2005077959A1 (en) * 2004-02-11 2005-08-25 Smithkline Beecham Corporation Pth agonists
EP1713782A4 (en) * 2004-02-11 2009-11-11 Smithkline Beecham Corp PTH AGONISTS
JP2008515895A (ja) 2004-10-07 2008-05-15 メルク エンド カムパニー インコーポレーテッド Ｃｇｒｐ受容体拮抗薬
WO2007135417A1 (en) 2006-05-19 2007-11-29 James Black Foundation Benzotriazepinone derivatives
AR061522A1 (es) 2006-06-20 2008-09-03 Wyeth Corp Derivados de 4-oxo-1, 3, 8-triaza[4.5]decanos como inhibidores del canal de potasio kv1.5, una composicion que los comprende y su empleo en el tratamiento de afecciones cardiacas.
JP2010529069A (ja) 2007-06-07 2010-08-26 エフ．ホフマン−ラ ロシュ アーゲー Ｎｋ３アンタゴニストとしてのプロリンアミド誘導体
KR101578235B1 (ko) 2007-12-10 2015-12-16 노파르티스 아게 유기 화합물
US7981904B2 (en) 2008-03-20 2011-07-19 Takeda Pharmaceutical Company Limited Acetyl CoA carboxylase inhibitors
US8513193B2 (en) 2008-10-13 2013-08-20 University Of Rochester Protecting and repairing cartilage and musculoskeletal soft tissues
PT2433940E (pt) 2009-04-28 2014-12-12 Chugai Pharmaceutical Co Ltd Derivado de espiroimidazolona
CN104854106B (zh) * 2012-12-10 2017-07-04 中外制药株式会社 乙内酰脲衍生物
EP3153166B1 (en) * 2014-06-09 2022-08-03 Chugai Seiyaku Kabushiki Kaisha Hydantoin derivative-containing pharmaceutical composition

Also Published As

Publication number Publication date
SA515360528B1 (ar) 2018-05-24
UA115072C2 (uk) 2017-09-11
CA2892621C (en) 2021-02-16
JP5951799B2 (ja) 2016-07-13
HK1209735A1 (en) 2016-04-08
MA38250A1 (fr) 2017-02-28
HUE037530T2 (hu) 2018-09-28
JPWO2014092061A1 (ja) 2017-01-12
CA2892621A1 (en) 2014-06-19
MX2015007309A (es) 2015-09-10
NZ707946A (en) 2019-11-29
KR102168738B1 (ko) 2020-10-22
SG11201504204XA (en) 2015-07-30
IL238277A0 (en) 2015-06-30
AU2013358167A1 (en) 2015-04-09
TW201439092A (zh) 2014-10-16
RU2678984C2 (ru) 2019-02-05
US9428505B2 (en) 2016-08-30
PL2930176T3 (pl) 2018-07-31
MA38250B1 (fr) 2017-10-31
PE20151295A1 (es) 2015-10-10
WO2014092061A1 (ja) 2014-06-19
US20220162208A1 (en) 2022-05-26
ZA201503597B (en) 2016-09-28
RU2015127624A (ru) 2017-01-16
AU2013358167B2 (en) 2017-09-14
CL2015001391A1 (es) 2015-07-31
US20210024524A1 (en) 2021-01-28
BR112015012411B1 (pt) 2021-10-05
US20180237436A1 (en) 2018-08-23
PH12015501146A1 (en) 2015-08-10
RS57190B1 (sr) 2018-07-31
HRP20180647T1 (hr) 2018-06-01
PH12015501146B1 (en) 2017-10-27
NO2930176T3 (es) 2018-07-07
BR112015012411A2 (pt) 2017-07-11
TWI615394B (zh) 2018-02-21
DK2930176T3 (en) 2018-03-19
IL238277B (en) 2018-01-31
CR20150272A (es) 2015-07-09
CN104854106A (zh) 2015-08-19
EP2930176B1 (en) 2018-02-07
US20150274727A1 (en) 2015-10-01
CN104854106B (zh) 2017-07-04
ES2663797T3 (es) 2018-04-17
EP2930176A1 (en) 2015-10-14
SI2930176T1 (en) 2018-06-29
MY178583A (en) 2020-10-16
US20160326175A1 (en) 2016-11-10
PT2930176T (pt) 2018-04-03
EP2930176A4 (en) 2016-06-01
LT2930176T (lt) 2018-04-10
KR20150092275A (ko) 2015-08-12

Similar Documents

Publication Publication Date Title
CL2017000069A1 (es) Derivado de hidantoina.
CR20130066A (es) Compuesto heterocíclico y su uso
UA113643C2 (xx) N-цикліламіди як нематоциди
BR112012030473A2 (pt) pesticidas baseados em derivados pirrolidina espiroheterocíclicos
UY34318A (es) ?derivados de isotiazolina útiles como compuestos insecticidas?
UY34591A (es) Compuestos de imidazopirrolidinona
UY34202A (es) Compuestos fungicidas 2-(2-clor0-4-(4-cloro-fenoxi)-fenil]-1-(1,2,4]triazol-1-1l-etanol alquilo sustituidos
MX2013002169A (es) Derivados de heteroarilpiperidina y de piperazina como fungicidas.
UY34156A (es) Compuestos inhibidores de metaloenzimas
UY34095A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina
UY34336A (es) Derivados 5-fluoro pirimidina disustituidos que contienen un grupo sulfoximina
UY33943A (es) Derivados espirocíclicos de isoxazolina como agentes antiparasitarios.
UY34515A (es) Triazolopiridinas sustituidas
UY34039A (es) Compuestos fungicidas
UY34374A (es) Benzilindazoles sustituidos
UY34075A (es) ?compuestos insecticidas a base de derivados de ariltioacetamida
CO6630158A2 (es) Derivados de cetoheteroarilpiperidina y de cetoheteroarilpiperazina como fungicidas
EA201101148A1 (ru) Новые гербициды
UY34013A (es) ?compuestos de cromenona con actividad anti-tumoral?.
MX371337B (es) Compuestos para protección de células.
EA201101060A1 (ru) Новые гербициды
DOP2015000059A (es) Amino-quinolinas como inhibidores de cinasa
EA201101146A1 (ru) Новые гербициды
CO6260091A2 (es) Derivados de iminopiridina y su uso
UY33976A (es) Derivados de pirazolo-pirimidina.